News Sentiment

PHVS sentiment intelligence

Pharvaris BV news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 51 Balanced news tone 49 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 34.94 Week of 17 Jul 2026
Weighted tone 51/100

Balanced news tone

Market reaction Balanced read

News tone and price action are not far from neutral.

Primary event Market update

83/100 classification confidence.

Company focus 40

directly relevant articles

Source quality 1

high-authority source matches

Trend context Trend active

-0.4% over one week, +6.5% over four weeks, trend active, and materially above fair value.

Latest direct headline Positive

Pharvaris publishes review on bradykinin B2 receptor research

Market Reaction

Balanced read

50/100 confidence

News tone and price action are not far from neutral.

Primary event Market update 83/100 classification
One-week reaction -0.4% Price digesting
Trend fit Trend active 6.5% over four weeks
Fair value 57.9% Materially above fair value

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 11
Neutral 29
Negative 9

Relevance

Why the article matched

Direct first
Direct company coverage 40
Industry context 9
Sector context 0

Sources

Coverage mix

Publishers
Stock Titan 13
Market source 8
TradingView 6
simplywall.st 3
Finviz 3
Investing.com 2
Stock Traders Daily 2
MT Newswires 2

Event Lens

What the news is about

Classified themes
Market update 31
Earnings 12
Analyst action 4
Macro sensitivity 1
Balance sheet 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 31-49 of 49
Stock Titan Direct company coverage

Pharvaris (PHVS) director’s 2,400-share Rule 10b5-1 stock sale detailed

Pharvaris N.V. director Johannes Gerardus Christiaan Petrus Schikan sold 2,400 shares of the company's common stock at a weighted average price of $35.1041 per share through a pre-arranged Rule 10b5-1 trading plan. The individual sale prices ranged from $35.00 to $35.30. After th

Tone
Negative 38/100
Event
Market update
Published
30 Jun 2026 03:34
Source
Stock Titan
GuruFocus Direct company coverage

Insider Sell: Schikan Johannes Gerardus Christiaan Petrus Sells Shares of Pharvaris NV (PHVS)

Schikan Johannes Gerardus Christiaan Petrus, a Director at Pharvaris NV (PHVS), sold 2,400 shares of the company on June 29, 2026. Following this transaction, he now holds 352,767 shares. Pharvaris NV, a clinical-stage company, focuses on developing oral therapies for hereditary

Tone
Negative 28/100
Event
Market update
Published
30 Jun 2026 00:39
Source
GuruFocus
Investing.com South Africa Direct company coverage

Form 144 Pharvaris N.V. For: 29 June By Investing.com

This article announces the filing of Form 144 for Pharvaris N.V. on June 29. It is a brief notice published by Investing.com, providing basic financial data like the company's stock symbol and current price movement, along with various financial market indices and commodity price

Tone
Neutral 50/100
Event
Macro sensitivity
Published
29 Jun 2026 21:40
Source
Investing.com South Africa
TradingView Direct company coverage

Price to book forward of Pharvaris N.V. – GETTEX:9EN

This article displays the "Price to book forward" metric for Pharvaris N.V. (9EN) on the Gettex exchange, as provided by TradingView. It shows the period, value, and change percentages for this financial indicator. The content is primarily a data placeholder within a financial pl

Tone
Neutral 50/100
Event
Market update
Published
29 Jun 2026 17:39
Source
TradingView
Stock Traders Daily Direct company coverage

Liquidity Mapping Around (PHVS) Price Events

This article provides a detailed liquidity mapping and analysis for Pharvaris N.v. (NASDAQ: PHVS), indicating strong sentiment and compelling upside potential. It outlines three AI-generated institutional trading strategies—Position Trading, Momentum Breakout, and Risk Hedging—al

Tone
Positive 71/100
Event
Balance sheet
Published
28 Jun 2026 08:38
Source
Stock Traders Daily
TradingView Direct company coverage

Price to book forward of Pharvaris N.V. – NASDAQ:PHVS

This article displays the "Price to book forward" metric for Pharvaris N.V. (NASDAQ: PHVS) on TradingView. It provides a specific period value and changes in percentage. The content is presented as part of the financial overview for the company.

Tone
Neutral 50/100
Event
Market update
Published
28 Jun 2026 02:39
Source
TradingView
TradingView Direct company coverage

Pharvaris N.V. Actuals & Estimates (NASDAQ:PHVS)

This article provides an overview of Pharvaris N.V. (PHVS) stock performance, financial estimates, and key metrics. It details the current stock price, historical highs and lows, analyst forecasts, and upcoming earnings report dates. The article also covers market capitalization,

Tone
Positive 61/100
Event
Earnings
Published
27 Jun 2026 08:09
Source
TradingView
TradingView Direct company coverage

Enterprise value to revenue forward of Pharvaris N.V. – LS:A2QNWS

The article provides a financial overview for Pharvaris N.V. (LS:A2QNWS), focusing on its enterprise value to revenue forward. It appears to be an entry from a financial data platform, presenting financial metrics without detailed textual analysis. The content is primarily a list

Tone
Neutral 50/100
Event
Earnings
Published
27 Jun 2026 08:09
Source
TradingView